Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Phytic acid, also known as myo-inositol 1,2,3,4,5,6-hexakisphosphate (IP6), is a naturally occurring polyphosphorylated carbohydrate found in high concentrations in plant seeds and mammalian cells (PubChem CID 890). In humans, it serves as a critical intracellular signaling molecule involved in diverse processes such as mRNA export, DNA repair, and vesicle trafficking (Shears, 2001, Cell). Pharmacologically, phytate is recognized for its potent ability to inhibit the formation and growth of hydroxyapatite crystals, the primary component of pathological calcifications (Schantl et al., 2017, Nature Communications). This property has led to its development as a therapeutic agent, most notably in the form of SNF472, which is being investigated for the treatment of calciphylaxis and vascular calcification in patients with end-stage renal disease (Perelló et al., 2018, Br J Clin Pharmacol). While it offers therapeutic benefits, phytate also acts as an antinutrient by chelating essential minerals like calcium, iron, and zinc, which can lead to deficiencies if dietary intake is high and mineral absorption is compromised (Lopez et al., 2002, Int J Food Sci Technol).
Phytate inhibits the formation and growth of hydroxyapatite crystals by binding to their surfaces (Schantl et al., 2017), and it also acts as an intracellular signaling molecule that modulates protein function and gene expression (Shears, 2001).
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on myo-Inositol 1,2,3,4,5,6-hexakisphosphate (IP6).